Teligent, Inc.

Form 483 issued May 20, 2019 · Buena, New Jersey

Inspection
Apr 22 – May 20, 2019
Investigator
Nancy M. Espinal
Observations
10
Pages
11
FEI number
1000526875

In short: On May 20, 2019, FDA issued a Form 483 with 10 observations to Teligent, Inc. in Buena, New Jersey (FEI 1000526875) after an inspection that ran Apr 22 – May 20, 2019. The investigator was Nancy M. Espinal. Most observations concern quality system and laboratory controls; the most-cited regulation is 21 CFR 211.165 (testing and release for distribution).

At a glance

Quality system and laboratory controls account for 8 of 10 observations.

Quality system5
Laboratory controls3
Production1
Other1

Most cited: 21 CFR 211.192 (2×) · 211.180 (2×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Drug products failing to meet established…

  2. 02

    Investigations of a failure of a batch or any of its components to meet any of…

  3. 03

    Laboratory records are deficient in that they do not include a statement of the results of…

  4. 04

    Written records are not always made of investigations into the failure of a batch or any…

6 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Teligent, Inc.?

FDA listed 10 observations on this Form 483, mostly about quality system, laboratory controls and production. The most-cited regulation is 21 CFR 211.165 (testing and release for distribution). The opening words of each observation are shown on this page.

Who inspected Teligent, Inc.?

Nancy M. Espinal is named on this Form 483, for the inspection of Apr 22 – May 20, 2019. Each investigator has a profile showing what they cite most.

When was Teligent, Inc. inspected by FDA?

The inspection ran Apr 22 – May 20, 2019, and the Form 483 is dated May 20, 2019.

How do I get the full Form 483 for Teligent, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free